Nervgen Pharma Corp Stock Technical Analysis
| NGEN Stock | CAD 2.87 0.08 2.87% |
As of the 30th of November, NervGen Pharma secures the Downside Deviation of 4.63, mean deviation of 3.24, and Risk Adjusted Performance of 0.0395. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NervGen Pharma Corp, as well as the relationship between them. Please verify NervGen Pharma Corp maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk to decide if NervGen Pharma Corp is priced some-what accurately, providing market reflects its recent price of 2.87 per share.
NervGen Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as NervGen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NervGenNervGen |
NervGen Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
NervGen Pharma Corp Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of NervGen Pharma Corp volatility. High ATR values indicate high volatility, and low values indicate low volatility.
NervGen Pharma Corp Trend Analysis
Use this graph to draw trend lines for NervGen Pharma Corp. You can use it to identify possible trend reversals for NervGen Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual NervGen Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.NervGen Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for NervGen Pharma Corp applied against its price change over selected period. The best fit line has a slop of 0.0003 , which may suggest that NervGen Pharma Corp market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted NervGen Pharma price change compared to its average price change.About NervGen Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of NervGen Pharma Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of NervGen Pharma Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on NervGen Pharma Corp price pattern first instead of the macroeconomic environment surrounding NervGen Pharma Corp. By analyzing NervGen Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of NervGen Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to NervGen Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Net Debt To EBITDA | 1.33 | 1.1 | 0.65 | 1.07 | Intangibles To Total Assets | 0.0264 | 0.0181 | 0.0393 | 0.0746 |
NervGen Pharma November 30, 2024 Technical Indicators
Most technical analysis of NervGen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NervGen from various momentum indicators to cycle indicators. When you analyze NervGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0395 | |||
| Market Risk Adjusted Performance | 0.3356 | |||
| Mean Deviation | 3.24 | |||
| Semi Deviation | 4.41 | |||
| Downside Deviation | 4.63 | |||
| Coefficient Of Variation | 2451.47 | |||
| Standard Deviation | 4.66 | |||
| Variance | 21.76 | |||
| Information Ratio | 0.0113 | |||
| Jensen Alpha | 0.1096 | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | 0.0114 | |||
| Treynor Ratio | 0.3256 | |||
| Maximum Drawdown | 32.94 | |||
| Value At Risk | (5.84) | |||
| Potential Upside | 6.15 | |||
| Downside Variance | 21.47 | |||
| Semi Variance | 19.43 | |||
| Expected Short fall | (3.75) | |||
| Skewness | (0.36) | |||
| Kurtosis | 4.5 |
Additional Tools for NervGen Stock Analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.